Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
Journal of Cardiovascular Ultrasound
;
: 140-144, 2013.
Article
Dans Anglais
| WPRIM
| ID: wpr-54460
ABSTRACT
The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Sulfonamides
/
Récepteur endothéline
/
Communications interauriculaires
/
Hypertension pulmonaire
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Journal of Cardiovascular Ultrasound
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS